2003
DOI: 10.1161/01.res.0000084381.86567.08
|View full text |Cite
|
Sign up to set email alerts
|

Cardioprotective Actions by a Water-Soluble Carbon Monoxide–Releasing Molecule

Abstract: Abstract-Carbon monoxide, which is generated in mammals during the degradation of heme by the enzyme heme oxygenase, is an important signaling mediator. Transition metal carbonyls have been recently shown to function as carbon monoxide-releasing molecules (CO-RMs) and to elicit distinct pharmacological activities in biological systems.In the present study, we report that a water-soluble form of CO-RM promotes cardioprotection in vitro and in vivo. Specifically, we found that tricarbonylchloro(glycinato)rutheni… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

22
641
2
1

Year Published

2007
2007
2016
2016

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 623 publications
(666 citation statements)
references
References 45 publications
22
641
2
1
Order By: Relevance
“…HO-1 is a very effective defensive system against oxidative stress-induced cardiac cell damage (Foresti et al, 2001) as well as cardiac ischemia-reperfusion injury and organ rejection (Soares et al, 1998;Clark et al, 2003;Motterlini et al, 2005) In addition, both CO and bilirubin, the two major products of heme degradation by heme oxygenase, have been demonstrated to exert a direct and significant protective effect both in cardiac tissue (Clark et al, 2000b and during cold preservation of organs (Sandouka et al, 2006). Therefore, HO-1 induction was expected to play a major role also in the experimental protocol that we have employed in the present study.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…HO-1 is a very effective defensive system against oxidative stress-induced cardiac cell damage (Foresti et al, 2001) as well as cardiac ischemia-reperfusion injury and organ rejection (Soares et al, 1998;Clark et al, 2003;Motterlini et al, 2005) In addition, both CO and bilirubin, the two major products of heme degradation by heme oxygenase, have been demonstrated to exert a direct and significant protective effect both in cardiac tissue (Clark et al, 2000b and during cold preservation of organs (Sandouka et al, 2006). Therefore, HO-1 induction was expected to play a major role also in the experimental protocol that we have employed in the present study.…”
Section: Discussionmentioning
confidence: 99%
“…This last aspect is of special interest for transplantation procedures as organs are usually kept at 4 o C in storage solutions before the actual transplant surgery. HO-1 and its products biliverdin, bilirubin and carbon monoxide exert beneficial effects that include protection against ischemia-reperfusion damage (Clark et al, 2000bForesti et al, 2001;Sandouka et al, 2006), mitigation of oxidative and nitrosative stress Kaur et al, 2003;Taille et al, 2005) and prolongation of graft survival of liver, heart and kidney allografts in experimental animal models of transplantation (Soares et al, 2001;Clark et al, 2003;Motterlini et al, 2005;Nakao et al, 2005). Because of its antioxidant and anti-inflammatory characteristics, the HO-1 pathway is potentially an excellent candidate to be exploited for amelioration of organ transplantation outcomes and survival Curcumin reduces cold storage-induced damage in human cardiac myoblasts Sandouka et al, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…Only prolonged treatment with high concentrations of CORM-1 was shown to be toxic [19]. CORM-3 (tricarbonylchloro (glycinate)ruthenium (II) ([Ru(CO) 3 Cl(glycinate)]) and inactive CORM-3 (iCORM-3) were previously described [20,21]. CORM-3 is a second generation CORM, and is an effective CO donor in vitro, ex vivo and in vitro, and does not affect cell viability for up to 50 µM [19,20].…”
Section: Methodsmentioning
confidence: 99%
“…After dissolving [Ru(CO) 3 Cl 2 ] 2 in 100% dimethylsulfoxide, tricarbonylchloro(glycinato)ruthenium(II) ([Ru(CO) 3 Cl(glycinate)] or CORM-3 was prepared by adding glycine as described previously. 36 Stock solutions of CORM-3 (0.11 mol l -1 ) were prepared by dissolving the compound in distilled water. As a negative control, inactive CORM-3 (iCORM-3) was prepared by dissolving CORM-3 in phosphate-buffered saline and allowing the liberation of CO for 18 h at 37 1C in a fume hood.…”
Section: In Vitro Treatment Of Mesenteric Arterioles With Carbon Monomentioning
confidence: 99%